Life Sciences & Healthcare

In a dynamic environment where changing regulatory requirements, long product cycles, complex intellectual property rights and cost pressure on healthcare pose constant challenges for our clients, we offer you access to our extensive team of savvy experts. Not only are they legally qualified; they also have a deep understanding of the relevant technical and business-related issues in the life sciences and healthcare sectors.
Life Sciences is a key consulting area for our firm, where we have special expertise and proven track record, providing you with comprehensive support with pharmaceuticals, biotech, healthcare, medtech and digital health.

Areas of Expertise

Our specialists can advise you in the following areas in particular:

  • Developing intellectual property strategies, patent management and exploitation of intellectual property rights, supplementary protection certificates and extensions of paediatric rights; freedom-to-operate investigations;
  • National and cross-border M&A and private equity transactions and financing for pharmaceutical, biotech, healthcare and medtech companies as well as structuring and implementing joint ventures and other cooperation agreements;
  • Hospital financing and cooperations;
  • Distribution and supply agreements, cooperation agreements, license agreements, manufacturing agreements, research and development agreements, employee invention agreements;
  • Patent litigation (infringement proceedings, invalidity proceedings, assignment and ownership disputes, licensing disputes);
  • Other commercial arbitration and litigation in the field of life sciences and health care;
  • Regulatory advice and compliance regarding the Therapeutic Products Act (regulatory data protection, advice on pharmaceutical products, cooperations with HCPs and HCOs etc.);
  • Advertising law regarding therapeutic products, trademark law and other labelling issues regarding pharmaceuticals, biotech and medtech;
  • Pricing of therapeutic products and representation before the Federal Office of Public Health
  • Competition law advice (price differentiation, distribution channel planning etc.);
  • E-health, data management, data protection strategies, advice in connection with digital business ideas and online platforms;
  • Outsourcing projects;
  • Product recall procedures

We are first movers in new areas of law, and were the first in Switzerland to establish a dedicated cannabis practice covering the regulatory and commercial aspects of the cannabis industry as well as investing into the cannabis industry.

More


MLL has “wide knowledge of the […] pharmaceutical business and a highly diligent approach”

Chambers 2020

Related to this Industry Group

Publications

Pharmaceutical Test Data Exclusivity: Switzerland

Pharmaceutical Test Data Exclusivity: A Multi-Jurisdictional Survey, AIPPI Law Series, Volume 7, 2022 Kluwer Law International BV, The Netherlands, p. 97-103, August 2022
  • EN

Die Zulässigkeit von Cannabis in kosmetischen Mitteln

Jusletter, 27. Juni 2022
  • DE

Medical Cannabis & Cannabinoid Regulation 2022 Switzerland – Law & Practice and Trends & Developments

Chambers and Partners, Global Practice Guides, Medical Cannabis & Cannabinoid Regulation, 20 June 2022
  • EN

Handel mit medizinischem Cannabis: Die Schweiz öffnet sich

krautinvest.de, Interview by Moritz Förster, 29. Mai 2022
  • DE